Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 4, Avril 2014
Page(s) 398 - 404
Section Microenvironnements tumoraux : conflictuels et complémentaires
DOI https://doi.org/10.1051/medsci/20143004013
Publié en ligne 5 mai 2014
  1. Allen M, Louise Jones J. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011 ; 223 : 162–176. [PubMed]
  2. Polanska UM, Orimo A. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol 2013 ; 228 : 1651–1657. [CrossRef] [PubMed]
  3. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012 ; 33 : 119–126. [CrossRef]
  4. Rajala MW, Scherer PE. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003 ; 144 : 3765–3773. [CrossRef] [PubMed]
  5. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004 ; 4 : 579–591. [CrossRef] [PubMed]
  6. Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev Nutr 2012 ; 32 : 311–342. [CrossRef] [PubMed]
  7. Dirat B, Bochet L, Escourrou G, et al. Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev 2010 ; 19 : 45–52. [CrossRef] [PubMed]
  8. Wang YY, Lehuede C, Laurent V, et al. Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. Cancer Lett 2012 ; 324 : 142–151. [CrossRef] [PubMed]
  9. Smorlesi A, Frontini A, Giordano A, Cinti S., The adipose organ: white-brown adipocyte plasticity, metabolic inflammation. Obes Rev 2012 ; 13 : suppl 2 : 83–96. [CrossRef] [PubMed]
  10. Tsoli M, Moore M, Burg D, et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer Res 2012 ; 72 : 4372–4382. [CrossRef] [PubMed]
  11. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature Rev Immunol 2011 ; 11 : 85–97. [CrossRef] [PubMed]
  12. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009 ; 48 : 275–297. [CrossRef] [PubMed]
  13. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005 ; 146 : 1764–1771. [CrossRef] [PubMed]
  14. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010 ; 316 : 129–139. [CrossRef] [PubMed]
  15. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006 ; 74 : 443–477. [CrossRef] [PubMed]
  16. Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011 ; 71 : 2455–2465. [CrossRef] [PubMed]
  17. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol 2012 ; 302 : C327–C359. [CrossRef] [PubMed]
  18. Elliott BE, Tam SP, Dexter D, Chen ZQ. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J Cancer 1992 ; 51 : 416–424. [CrossRef] [PubMed]
  19. Manabe Y, Toda S, Miyazaki K, Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003 ; 201 : 221–228. [CrossRef] [PubMed]
  20. Hefetz-Sela S, Scherer PE. Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention. Pharmacol Ther 2013 ; 138 : 197–210. [CrossRef] [PubMed]
  21. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013 ; 1831 : 1533–1541. [CrossRef] [PubMed]
  22. Andarawewa KL, Motrescu ER, Chenard MP, et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 2005 ; 65 : 10862–10871. [CrossRef] [PubMed]
  23. Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011 ; 17 : 1498–1503. [CrossRef] [PubMed]
  24. Finley DS, Calvert VS, Inokuchi J, et al. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol 2009 ; 182 : 1621–1627. [CrossRef] [PubMed]
  25. Wagner M, Bjerkvig R, Wiig H, et al. Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis 2012 ; 15 : 481–495. [CrossRef] [PubMed]
  26. Iyengar P, Espina V, Williams TW, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005 ; 115 : 1163–1176. [CrossRef] [PubMed]
  27. Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest 2012 ; 122 : 4243–4256. [CrossRef] [PubMed]
  28. Motrescu ER, Blaise S, Etique N, et al. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 2008 ; 27 : 6347–6355. [CrossRef] [PubMed]
  29. Gazi E, Gardner P, Lockyer NP, et al. Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res 2007 ; 48 : 1846–1856. [CrossRef] [PubMed]
  30. Bochet L, Meulle A, Imbert S, et al. Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun 2011 ; 411 : 102–106. [CrossRef] [PubMed]
  31. Behan JW, Yun JP, Proektor MP, et al. Adipocytes impair leukemia treatment in mice. Cancer Res 2009 ; 69 : 7867–7874. [CrossRef] [PubMed]
  32. Park J, Morley TS, Scherer PE. Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med 2013 ; 5 : 935–948. [CrossRef] [PubMed]
  33. Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocrine Rev 2011 ; 32 : 550–570. [CrossRef]
  34. Rose DP, Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocrine Relat Cancer 2012 ; 19 : R225–R241. [CrossRef]
  35. Divoux A, Clement K. Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obesity Rev 2011 ; 12 : e494–e503. [CrossRef]
  36. Carrière A, Jeanson Y, Cousin B, et al. Le recrutement et l’activation d’adipocytes bruns et/ou BRITE : une perspective réelle pour le traitement des maladies métaboliques ? Med Sci (Paris) 2013 ; 29 : 729–735. [CrossRef] [EDP Sciences] [PubMed]
  37. Le Guellec S, Duprez-Paumier R, Lacroix-Triki M. Microenvironnement tumoral : la vision du pathologiste. Med Sci (Paris) 2014 ; 30 : 372–377. [CrossRef] [EDP Sciences] [PubMed]
  38. Provot S. Contrôle de la croissance et de la dissémination tumorales par le microenvironnement : certitudes et hypothèses émergentes. Med Sci (Paris) 2014 ; 30 : 366–371. [CrossRef] [EDP Sciences] [PubMed]
  39. Hasmim M, Messai Y, Zaeem M, Chouaib S. L’hypoxie tumorale : un déterminant clé de la réactivité stromale et de la réponse antitumorale. Med Sci (Paris) 2014 ; 30 : 422–428. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.